Zacks Research Issues Pessimistic Forecast for BAX Earnings

Baxter International Inc. (NYSE:BAX) – Equities researchers at Zacks Research lowered their Q3 2026 earnings per share estimates for Baxter International in a research report issued on Monday, September 28th. Zacks Research analyst Team now anticipates that the medical instruments supplier will post earnings of $0.51 per share for the quarter, down from their prior estimate of $0.53. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share. Zacks Research also issued estimates for Baxter International’s Q4 2026 earnings at $0.60 EPS, FY2026 earnings at $2.04 EPS, Q3 2027 earnings at $0.50 EPS, Q4 2027 earnings at $0.52 EPS, FY2027 earnings at $1.98 EPS and FY2028 earnings at $2.11 EPS.

A number of other equities analysts have also recently issued reports on the stock. The Goldman Sachs Group increased their price objective on shares of Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. TD Cowen boosted their target price on Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Citigroup raised Baxter International from a “sell” rating to a “neutral” rating and upped their price target for the stock from $17.00 to $28.00 in a research note on Friday, July 31st. Wall Street Zen upgraded Baxter International from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Finally, Stifel Nicolaus raised their price objective on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Two analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $22.45.

Baxter International Trading Down 1.6%

BAX opened at $23.62 on Wednesday. Baxter International has a 1-year low of $15.73 and a 1-year high of $30.00. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The company has a market cap of $12.21 billion, a P/E ratio of -11.41, a price-to-earnings-growth ratio of 3.63 and a beta of 0.66. The company has a fifty day moving average price of $25.30 and a two-hundred day moving average price of $21.29.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The company’s revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Jones Financial Companies Lllp purchased a new position in Baxter International during the 2nd quarter worth $26,000. CYBER HORNET ETFs LLC lifted its position in shares of Baxter International by 52.4% during the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after purchasing an additional 740 shares in the last quarter. Community Bank N.A. purchased a new position in Baxter International during the second quarter worth about $46,000. Versant Capital Management Inc grew its position in Baxter International by 552.2% in the 2nd quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 2,043 shares in the last quarter. Finally, EFG International AG bought a new stake in Baxter International in the 2nd quarter worth about $67,000. Hedge funds and other institutional investors own 90.19% of the company’s stock.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were paid a $0.01 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s dividend payout ratio is -1.93%.

Key Stories Impacting Baxter International

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter released its inaugural Connected Hospital Report, highlighting the potential for connected medical technologies to improve hospital efficiency, patient care and clinical decision-making. The report may strengthen Baxter’s strategic positioning in digital and connected healthcare, although it does not provide a material near-term financial update. Baxter Releases Inaugural Connected Hospital Report

About Baxter International

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.